Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-062937
Filing Date
2025-05-02
Accepted
2025-05-02 17:20:43
Documents
1
Period of Report
2025-05-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3870
  Complete submission text file 0000950170-25-062937.txt   5309
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Issuer) CIK: 0001339970 (see all company filings)

EIN.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 2401 4TH AVENUE, SUITE 1050 SEATTLE WA 98121
Business Address
Gross Jane A (Reporting) CIK: 0001684258 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37378 | Film No.: 25910053